![David N. Bell](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Perfil
David N.
Bell worked as the Chief Scientific Officer & VP-Drug Development at Therapure Biopharma, Inc. from 2007 to 2020.
Prior to that, he was the Vice President-Drug Development & Research at 1608557 Ontario, Inc. He received a graduate degree from McGill University and a doctorate in 1988 from the same institution.
Antiguos cargos conocidos de David N. Bell.
| Empresas | Cargo | Fin |
|---|---|---|
Therapure Biopharma, Inc.
 Therapure Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Director Técnico/Científico/I+D | 01/01/2020 |
1608557 Ontario, Inc.
 1608557 Ontario, Inc. BiotechnologyHealth Technology Develops and manufacturers biologics, particularly blood-related based therapeutics | Director Técnico/Científico/I+D | - |
Formación de David N. Bell.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
98
Relaciones de 1er grado
3
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 3 |
|---|---|
Therapure Biopharma, Inc.
Therapure Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
McGill University
 McGill University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
1608557 Ontario, Inc.
1608557 Ontario, Inc. BiotechnologyHealth Technology Develops and manufacturers biologics, particularly blood-related based therapeutics | Health Technology |
- Bolsa de valores
- Insiders
- David N. Bell
